Download Files:
Products Details
Product Description
– CCG-232964 is an orally active inhibitor of Rho/MRTF/SRF. CCG-232964 inhibits LPA-induced CTGF gene expression[1].
Web ID
– HY-130011
Shipping
– Room temperature
Molecular Formula
– C15H15ClN2O3S
References
– [1]Kahl, Dylan, et al. 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Reponse Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma. Journal of Medicinal Chemistry, (), acs.jmedchem.8b01772–.
CAS Number
– 2349373-70-0
Molecular Weight
– 338.81
SMILES
– O=C(O)CCCSC1=NN=C(C2=CC=C(C3CC3)C=C2Cl)O1
Clinical Information
– No Development Reported
Research Area
– Cancer; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Ras;ROCK
Pathway
– Cell Cycle/DNA Damage;Cytoskeleton;GPCR/G Protein;Stem Cell/Wnt;TGF-beta/Smad
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
